XETRA · BNN.DE
BRAIN Biotech AG
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
Loading market information…
XETRA · NN6.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
NanoRepro AG’s quoted price sits in the lower half of its reported 52-week range, 31.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
NanoRepro AG’s forward annual dividend is €0.15 per share, paid annual. The forward yield is 9.17% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
NanoRepro AG’s next earnings report is currently expected on May 14, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow NanoRepro AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Marburg, Germany, NanoRepro AG specializes in the development, manufacturing, and international distribution of both swift diagnostic tests and nutritional supplements, serving individual consumers and healthcare professionals alike. Their diagnostic offerings encompass family planning, various disease detection, identification of food intolerances, allergies, and infectious diseases. This portfolio includes dedicated rapid test lines for allergies, family planning, and preventive healthcare. For hospitals and medical practices, they provide point-of-care tests capable of detecting conditions such as HIV, human cardiac Troponin I, D-dimer, streptococci antigens, influenza types A and B, and microalbumin. The company also produces immunochromatographic lateral flow tests for biomarker identification, alongside rapid SARS-CoV-2 antibody and antigen tests. Complementing their diagnostics, NanoRepro AG offers food supplements tailored for men and women, distributed via online stores and pharmacies.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
€20.20+€0.20 (+1.0%)
MeVis Medical Solutions AG’s quoted price sits in the lower half of its reported 52-week range, 24.63% below the high.
€1.48€0.00 (0.0%)
aap Implantate AG’s quoted price sits in the lower half of its reported 52-week range, 36.75% below the high.
€0.92+€0.08 (+9.58%)
Maternus-Kliniken AG’s quoted price sits in the lower half of its reported 52-week range, 91.61% below the high.
€2.11-€0.07 (-3.21%)
Geratherm Medical AG’s quoted price sits in the lower half of its reported 52-week range, 55.01% below the high.
€7.40-€0.45 (-5.73%)
AS Latvijas Juras medicinas centrs’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
€0.28-€0.01 (-3.45%)
SynBiotic SE’s quoted price sits in the lower half of its reported 52-week range, 92.73% below the high.
A$0.08A$0.00 (0.0%)
Oakridge International Limited’s quoted price sits in the lower half of its reported 52-week range, 44.83% below the high.
